Guanfacine as a potential preventive therapy for chronic migraine: a mechanistic hypothesis.

Guanfacine is a medication that may help prevent chronic migraines. Many patients still struggle with migraines despite existing treatments. About one-third of chronic migraine patients do not find relief. Current oral preventive therapies often have side effects. Guanfacine is already approved for treating high blood pressure and ADHD. Researchers believe it could work against chronic migraines in three ways. First, it might reduce the release of certain pain-related chemicals in the brain. Second, it could lower the sensitivity of pain pathways. Finally, it may help regulate blood flow in the brain. This could lead to fewer migraine attacks for patients. More research is needed to confirm these ideas. However, guanfacine presents a promising new option for those suffering from chronic migraines. It may offer a better alternative to existing treatments that have limited effectiveness or cause unwanted side effects. Clinical relevance: This research suggests guanfacine may provide a new preventive option for chronic migraine patients, potentially improving treatment outcomes and reducing reliance on current therapies.